USA: Process Monitoring and Reporting Merck Acquires Data Management and Analysis Platform
Merck has acquired all ownership rights to the Process Pad platform from Simplyfeye Softwares. The web-based platform provides on-demand access, across functions and with suppliers, to data for aggregation, analysis, visualization and management.
Pittsburgh/USA — Simplyfeye has agreed with Merck to transfer all copyrights and relevant intellectual property related to the Process Pad software platform. This platform is a data management and analytics solution developed specifically for the pharmaceutical and biopharmaceutical industry. The platform aggregates data from a variety of external data sources for various batches, parameters and unit operations, efficiently capturing all development, scale-up, commercial and process data on one single platform. It analyzes quantitative and qualitative batch manufacturing data using various process analysis tools, which also aid in troubleshooting. Process Pad also visualizes the data by generating a variety of report, charts, and tables for annual product reviews, root cause investigations and corrective and preventive action (Capa) implementation, etc. The software helps users manage data through browser-based access to all process data from a variety of diverse stakeholders.
The acquisition of the platform is another building block for Merck’s Bio Continuum Platform, a confluent offering of intensified, advanced processing and digital technologies and services that allow a customer to go beyond continuous processing. The platform is to deliver contiguous manufacturing for Biopharma 4.0, the industry-specific global vision and initiative based on Industry 4.0.